RepliCel Life Sciences Preço/Valor Contábil
Qual é o Preço/Valor Contábil de RepliCel Life Sciences?
O Preço/Valor Contábil de RepliCel Life Sciences, Inc. é -0.77
Qual é a definição de Preço/Valor Contábil?
A razão entre cotação e valor contabilístico representa a razão entre o valor das ações de uma empresa e o valor contábil por ação.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Preço/Valor Contábil de empresas na Setor Health Care em TSXV em comparação com RepliCel Life Sciences
O que RepliCel Life Sciences faz?
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
Empresas com preço/valor contábil semelhantes a RepliCel Life Sciences
- Gayatri Sugars tem Preço/Valor Contábil de -0.77
- CVR Medical tem Preço/Valor Contábil de -0.77
- QDM International tem Preço/Valor Contábil de -0.77
- Collaborate tem Preço/Valor Contábil de -0.77
- TrustBIX tem Preço/Valor Contábil de -0.77
- Starlite Components tem Preço/Valor Contábil de -0.77
- RepliCel Life Sciences tem Preço/Valor Contábil de -0.77
- Bitcoin Well Inc tem Preço/Valor Contábil de -0.76
- Wheeler Real Estate Investment Trust Inc tem Preço/Valor Contábil de -0.76
- Pioneer Distilleries tem Preço/Valor Contábil de -0.76
- Maple Leaf Green World tem Preço/Valor Contábil de -0.76
- Management Consulting PLC tem Preço/Valor Contábil de -0.75
- Alok Industries tem Preço/Valor Contábil de -0.75